Global Human Microbiome Based Drugs and Diagnostics Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-human-microbiome-based-drugs-n-diagnostics-market-research-report-2024status-n-outlook_en.gif)
Report Overview:
The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.
The Global Human Microbiome Based Drugs and Diagnostics Market Size was estimated at USD 460.72 million in 2023 and is projected to reach USD 829.64 million by 2029, exhibiting a CAGR of 10.30% during the forecast period.
This report provides a deep insight into the global Human Microbiome Based Drugs and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Microbiome Based Drugs and Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Microbiome Based Drugs and Diagnostics market in any manner.
Global Human Microbiome Based Drugs and Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Second Genome
Enterome Bioscience
Yakult
Dowdupont
Vedanta BioSciences
Metabiomics Corporation
ViThera Pharmaceuticals
MicroBiome Therapeutics
Osel
Merck
Market Segmentation (by Type)
Therapeutics
Diagnostics
Market Segmentation (by Application)
Clinical Research Institutes
Hospital
Surgical Centers
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Microbiome Based Drugs and Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.
The Global Human Microbiome Based Drugs and Diagnostics Market Size was estimated at USD 460.72 million in 2023 and is projected to reach USD 829.64 million by 2029, exhibiting a CAGR of 10.30% during the forecast period.
This report provides a deep insight into the global Human Microbiome Based Drugs and Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Microbiome Based Drugs and Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Microbiome Based Drugs and Diagnostics market in any manner.
Global Human Microbiome Based Drugs and Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Second Genome
Enterome Bioscience
Yakult
Dowdupont
Vedanta BioSciences
Metabiomics Corporation
ViThera Pharmaceuticals
MicroBiome Therapeutics
Osel
Merck
Market Segmentation (by Type)
Therapeutics
Diagnostics
Market Segmentation (by Application)
Clinical Research Institutes
Hospital
Surgical Centers
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Human Microbiome Based Drugs and Diagnostics Market
- Overview of the regional outlook of the Human Microbiome Based Drugs and Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Microbiome Based Drugs and Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Microbiome Based Drugs and Diagnostics
1.2 Key Market Segments
1.2.1 Human Microbiome Based Drugs and Diagnostics Segment by Type
1.2.2 Human Microbiome Based Drugs and Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Microbiome Based Drugs and Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Microbiome Based Drugs and Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Microbiome Based Drugs and Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Microbiome Based Drugs and Diagnostics Sales Sites, Area Served, Product Type
3.6 Human Microbiome Based Drugs and Diagnostics Market Competitive Situation and Trends
3.6.1 Human Microbiome Based Drugs and Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Microbiome Based Drugs and Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Human Microbiome Based Drugs and Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Human Microbiome Based Drugs and Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Human Microbiome Based Drugs and Diagnostics Price by Type (2019-2024)
7 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Microbiome Based Drugs and Diagnostics Market Sales by Application (2019-2024)
7.3 Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Human Microbiome Based Drugs and Diagnostics Sales Growth Rate by Application (2019-2024)
8 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Human Microbiome Based Drugs and Diagnostics Sales by Region
8.1.1 Global Human Microbiome Based Drugs and Diagnostics Sales by Region
8.1.2 Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Human Microbiome Based Drugs and Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Microbiome Based Drugs and Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Microbiome Based Drugs and Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Second Genome
9.1.1 Second Genome Human Microbiome Based Drugs and Diagnostics Basic Information
9.1.2 Second Genome Human Microbiome Based Drugs and Diagnostics Product Overview
9.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.1.4 Second Genome Business Overview
9.1.5 Second Genome Human Microbiome Based Drugs and Diagnostics SWOT Analysis
9.1.6 Second Genome Recent Developments
9.2 Enterome Bioscience
9.2.1 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Basic Information
9.2.2 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Overview
9.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.2.4 Enterome Bioscience Business Overview
9.2.5 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics SWOT Analysis
9.2.6 Enterome Bioscience Recent Developments
9.3 Yakult
9.3.1 Yakult Human Microbiome Based Drugs and Diagnostics Basic Information
9.3.2 Yakult Human Microbiome Based Drugs and Diagnostics Product Overview
9.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.3.4 Yakult Human Microbiome Based Drugs and Diagnostics SWOT Analysis
9.3.5 Yakult Business Overview
9.3.6 Yakult Recent Developments
9.4 Dowdupont
9.4.1 Dowdupont Human Microbiome Based Drugs and Diagnostics Basic Information
9.4.2 Dowdupont Human Microbiome Based Drugs and Diagnostics Product Overview
9.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.4.4 Dowdupont Business Overview
9.4.5 Dowdupont Recent Developments
9.5 Vedanta BioSciences
9.5.1 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Basic Information
9.5.2 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Overview
9.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.5.4 Vedanta BioSciences Business Overview
9.5.5 Vedanta BioSciences Recent Developments
9.6 Metabiomics Corporation
9.6.1 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Basic Information
9.6.2 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Overview
9.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.6.4 Metabiomics Corporation Business Overview
9.6.5 Metabiomics Corporation Recent Developments
9.7 ViThera Pharmaceuticals
9.7.1 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Basic Information
9.7.2 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Overview
9.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.7.4 ViThera Pharmaceuticals Business Overview
9.7.5 ViThera Pharmaceuticals Recent Developments
9.8 MicroBiome Therapeutics
9.8.1 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Basic Information
9.8.2 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Overview
9.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.8.4 MicroBiome Therapeutics Business Overview
9.8.5 MicroBiome Therapeutics Recent Developments
9.9 Osel
9.9.1 Osel Human Microbiome Based Drugs and Diagnostics Basic Information
9.9.2 Osel Human Microbiome Based Drugs and Diagnostics Product Overview
9.9.3 Osel Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.9.4 Osel Business Overview
9.9.5 Osel Recent Developments
9.10 Merck
9.10.1 Merck Human Microbiome Based Drugs and Diagnostics Basic Information
9.10.2 Merck Human Microbiome Based Drugs and Diagnostics Product Overview
9.10.3 Merck Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
10 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast
10.2 Global Human Microbiome Based Drugs and Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Region
10.2.4 South America Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Microbiome Based Drugs and Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Microbiome Based Drugs and Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Microbiome Based Drugs and Diagnostics by Type (2025-2030)
11.1.2 Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Microbiome Based Drugs and Diagnostics by Type (2025-2030)
11.2 Global Human Microbiome Based Drugs and Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Microbiome Based Drugs and Diagnostics
1.2 Key Market Segments
1.2.1 Human Microbiome Based Drugs and Diagnostics Segment by Type
1.2.2 Human Microbiome Based Drugs and Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Microbiome Based Drugs and Diagnostics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Microbiome Based Drugs and Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Microbiome Based Drugs and Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Microbiome Based Drugs and Diagnostics Sales Sites, Area Served, Product Type
3.6 Human Microbiome Based Drugs and Diagnostics Market Competitive Situation and Trends
3.6.1 Human Microbiome Based Drugs and Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Microbiome Based Drugs and Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Human Microbiome Based Drugs and Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Human Microbiome Based Drugs and Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Human Microbiome Based Drugs and Diagnostics Price by Type (2019-2024)
7 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Microbiome Based Drugs and Diagnostics Market Sales by Application (2019-2024)
7.3 Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Human Microbiome Based Drugs and Diagnostics Sales Growth Rate by Application (2019-2024)
8 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET SEGMENTATION BY REGION
8.1 Global Human Microbiome Based Drugs and Diagnostics Sales by Region
8.1.1 Global Human Microbiome Based Drugs and Diagnostics Sales by Region
8.1.2 Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Human Microbiome Based Drugs and Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Microbiome Based Drugs and Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Microbiome Based Drugs and Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Second Genome
9.1.1 Second Genome Human Microbiome Based Drugs and Diagnostics Basic Information
9.1.2 Second Genome Human Microbiome Based Drugs and Diagnostics Product Overview
9.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.1.4 Second Genome Business Overview
9.1.5 Second Genome Human Microbiome Based Drugs and Diagnostics SWOT Analysis
9.1.6 Second Genome Recent Developments
9.2 Enterome Bioscience
9.2.1 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Basic Information
9.2.2 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Overview
9.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.2.4 Enterome Bioscience Business Overview
9.2.5 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics SWOT Analysis
9.2.6 Enterome Bioscience Recent Developments
9.3 Yakult
9.3.1 Yakult Human Microbiome Based Drugs and Diagnostics Basic Information
9.3.2 Yakult Human Microbiome Based Drugs and Diagnostics Product Overview
9.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.3.4 Yakult Human Microbiome Based Drugs and Diagnostics SWOT Analysis
9.3.5 Yakult Business Overview
9.3.6 Yakult Recent Developments
9.4 Dowdupont
9.4.1 Dowdupont Human Microbiome Based Drugs and Diagnostics Basic Information
9.4.2 Dowdupont Human Microbiome Based Drugs and Diagnostics Product Overview
9.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.4.4 Dowdupont Business Overview
9.4.5 Dowdupont Recent Developments
9.5 Vedanta BioSciences
9.5.1 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Basic Information
9.5.2 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Overview
9.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.5.4 Vedanta BioSciences Business Overview
9.5.5 Vedanta BioSciences Recent Developments
9.6 Metabiomics Corporation
9.6.1 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Basic Information
9.6.2 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Overview
9.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.6.4 Metabiomics Corporation Business Overview
9.6.5 Metabiomics Corporation Recent Developments
9.7 ViThera Pharmaceuticals
9.7.1 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Basic Information
9.7.2 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Overview
9.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.7.4 ViThera Pharmaceuticals Business Overview
9.7.5 ViThera Pharmaceuticals Recent Developments
9.8 MicroBiome Therapeutics
9.8.1 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Basic Information
9.8.2 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Overview
9.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.8.4 MicroBiome Therapeutics Business Overview
9.8.5 MicroBiome Therapeutics Recent Developments
9.9 Osel
9.9.1 Osel Human Microbiome Based Drugs and Diagnostics Basic Information
9.9.2 Osel Human Microbiome Based Drugs and Diagnostics Product Overview
9.9.3 Osel Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.9.4 Osel Business Overview
9.9.5 Osel Recent Developments
9.10 Merck
9.10.1 Merck Human Microbiome Based Drugs and Diagnostics Basic Information
9.10.2 Merck Human Microbiome Based Drugs and Diagnostics Product Overview
9.10.3 Merck Human Microbiome Based Drugs and Diagnostics Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
10 HUMAN MICROBIOME BASED DRUGS AND DIAGNOSTICS MARKET FORECAST BY REGION
10.1 Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast
10.2 Global Human Microbiome Based Drugs and Diagnostics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country
10.2.3 Asia Pacific Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Region
10.2.4 South America Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Microbiome Based Drugs and Diagnostics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Human Microbiome Based Drugs and Diagnostics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Microbiome Based Drugs and Diagnostics by Type (2025-2030)
11.1.2 Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Microbiome Based Drugs and Diagnostics by Type (2025-2030)
11.2 Global Human Microbiome Based Drugs and Diagnostics Market Forecast by Application (2025-2030)
11.2.1 Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) Forecast by Application
11.2.2 Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Microbiome Based Drugs and Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Microbiome Based Drugs and Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Microbiome Based Drugs and Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2022)
Table 10. Global Market Human Microbiome Based Drugs and Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Microbiome Based Drugs and Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Human Microbiome Based Drugs and Diagnostics Product Type
Table 13. Global Human Microbiome Based Drugs and Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Microbiome Based Drugs and Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Microbiome Based Drugs and Diagnostics Market Challenges
Table 22. Global Human Microbiome Based Drugs and Diagnostics Sales by Type (K Units)
Table 23. Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (M USD)
Table 24. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Human Microbiome Based Drugs and Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) by Application
Table 30. Global Human Microbiome Based Drugs and Diagnostics Market Size by Application
Table 31. Global Human Microbiome Based Drugs and Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Human Microbiome Based Drugs and Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application (2019-2024)
Table 35. Global Human Microbiome Based Drugs and Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Microbiome Based Drugs and Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Human Microbiome Based Drugs and Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Human Microbiome Based Drugs and Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Human Microbiome Based Drugs and Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Second Genome Human Microbiome Based Drugs and Diagnostics Basic Information
Table 44. Second Genome Human Microbiome Based Drugs and Diagnostics Product Overview
Table 45. Second Genome Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Second Genome Business Overview
Table 47. Second Genome Human Microbiome Based Drugs and Diagnostics SWOT Analysis
Table 48. Second Genome Recent Developments
Table 49. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Basic Information
Table 50. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Overview
Table 51. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Enterome Bioscience Business Overview
Table 53. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics SWOT Analysis
Table 54. Enterome Bioscience Recent Developments
Table 55. Yakult Human Microbiome Based Drugs and Diagnostics Basic Information
Table 56. Yakult Human Microbiome Based Drugs and Diagnostics Product Overview
Table 57. Yakult Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Yakult Human Microbiome Based Drugs and Diagnostics SWOT Analysis
Table 59. Yakult Business Overview
Table 60. Yakult Recent Developments
Table 61. Dowdupont Human Microbiome Based Drugs and Diagnostics Basic Information
Table 62. Dowdupont Human Microbiome Based Drugs and Diagnostics Product Overview
Table 63. Dowdupont Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Dowdupont Business Overview
Table 65. Dowdupont Recent Developments
Table 66. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Basic Information
Table 67. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Overview
Table 68. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Vedanta BioSciences Business Overview
Table 70. Vedanta BioSciences Recent Developments
Table 71. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Basic Information
Table 72. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Overview
Table 73. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Metabiomics Corporation Business Overview
Table 75. Metabiomics Corporation Recent Developments
Table 76. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Basic Information
Table 77. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Overview
Table 78. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. ViThera Pharmaceuticals Business Overview
Table 80. ViThera Pharmaceuticals Recent Developments
Table 81. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Basic Information
Table 82. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Overview
Table 83. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. MicroBiome Therapeutics Business Overview
Table 85. MicroBiome Therapeutics Recent Developments
Table 86. Osel Human Microbiome Based Drugs and Diagnostics Basic Information
Table 87. Osel Human Microbiome Based Drugs and Diagnostics Product Overview
Table 88. Osel Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Osel Business Overview
Table 90. Osel Recent Developments
Table 91. Merck Human Microbiome Based Drugs and Diagnostics Basic Information
Table 92. Merck Human Microbiome Based Drugs and Diagnostics Product Overview
Table 93. Merck Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Human Microbiome Based Drugs and Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Human Microbiome Based Drugs and Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Human Microbiome Based Drugs and Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Human Microbiome Based Drugs and Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Microbiome Based Drugs and Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Microbiome Based Drugs and Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Microbiome Based Drugs and Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2022)
Table 10. Global Market Human Microbiome Based Drugs and Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Microbiome Based Drugs and Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Human Microbiome Based Drugs and Diagnostics Product Type
Table 13. Global Human Microbiome Based Drugs and Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Microbiome Based Drugs and Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Microbiome Based Drugs and Diagnostics Market Challenges
Table 22. Global Human Microbiome Based Drugs and Diagnostics Sales by Type (K Units)
Table 23. Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (M USD)
Table 24. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Human Microbiome Based Drugs and Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) by Application
Table 30. Global Human Microbiome Based Drugs and Diagnostics Market Size by Application
Table 31. Global Human Microbiome Based Drugs and Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Human Microbiome Based Drugs and Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application (2019-2024)
Table 35. Global Human Microbiome Based Drugs and Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Microbiome Based Drugs and Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Human Microbiome Based Drugs and Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Human Microbiome Based Drugs and Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Human Microbiome Based Drugs and Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Second Genome Human Microbiome Based Drugs and Diagnostics Basic Information
Table 44. Second Genome Human Microbiome Based Drugs and Diagnostics Product Overview
Table 45. Second Genome Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Second Genome Business Overview
Table 47. Second Genome Human Microbiome Based Drugs and Diagnostics SWOT Analysis
Table 48. Second Genome Recent Developments
Table 49. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Basic Information
Table 50. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product Overview
Table 51. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Enterome Bioscience Business Overview
Table 53. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics SWOT Analysis
Table 54. Enterome Bioscience Recent Developments
Table 55. Yakult Human Microbiome Based Drugs and Diagnostics Basic Information
Table 56. Yakult Human Microbiome Based Drugs and Diagnostics Product Overview
Table 57. Yakult Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Yakult Human Microbiome Based Drugs and Diagnostics SWOT Analysis
Table 59. Yakult Business Overview
Table 60. Yakult Recent Developments
Table 61. Dowdupont Human Microbiome Based Drugs and Diagnostics Basic Information
Table 62. Dowdupont Human Microbiome Based Drugs and Diagnostics Product Overview
Table 63. Dowdupont Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Dowdupont Business Overview
Table 65. Dowdupont Recent Developments
Table 66. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Basic Information
Table 67. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product Overview
Table 68. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Vedanta BioSciences Business Overview
Table 70. Vedanta BioSciences Recent Developments
Table 71. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Basic Information
Table 72. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product Overview
Table 73. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Metabiomics Corporation Business Overview
Table 75. Metabiomics Corporation Recent Developments
Table 76. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Basic Information
Table 77. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product Overview
Table 78. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. ViThera Pharmaceuticals Business Overview
Table 80. ViThera Pharmaceuticals Recent Developments
Table 81. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Basic Information
Table 82. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Product Overview
Table 83. MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. MicroBiome Therapeutics Business Overview
Table 85. MicroBiome Therapeutics Recent Developments
Table 86. Osel Human Microbiome Based Drugs and Diagnostics Basic Information
Table 87. Osel Human Microbiome Based Drugs and Diagnostics Product Overview
Table 88. Osel Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Osel Business Overview
Table 90. Osel Recent Developments
Table 91. Merck Human Microbiome Based Drugs and Diagnostics Basic Information
Table 92. Merck Human Microbiome Based Drugs and Diagnostics Product Overview
Table 93. Merck Human Microbiome Based Drugs and Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Human Microbiome Based Drugs and Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Human Microbiome Based Drugs and Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Human Microbiome Based Drugs and Diagnostics Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Human Microbiome Based Drugs and Diagnostics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Microbiome Based Drugs and Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Microbiome Based Drugs and Diagnostics Market Size by Country (M USD)
Figure 11. Human Microbiome Based Drugs and Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Human Microbiome Based Drugs and Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Microbiome Based Drugs and Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Microbiome Based Drugs and Diagnostics Market Share by Type
Figure 18. Sales Market Share of Human Microbiome Based Drugs and Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Human Microbiome Based Drugs and Diagnostics by Type in 2023
Figure 20. Market Size Share of Human Microbiome Based Drugs and Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Human Microbiome Based Drugs and Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application
Figure 24. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application in 2023
Figure 28. Global Human Microbiome Based Drugs and Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Human Microbiome Based Drugs and Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Human Microbiome Based Drugs and Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Human Microbiome Based Drugs and Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Human Microbiome Based Drugs and Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region in 2023
Figure 44. China Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Human Microbiome Based Drugs and Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Microbiome Based Drugs and Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Human Microbiome Based Drugs and Diagnostics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Human Microbiome Based Drugs and Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD), 2019-2030
Figure 5. Global Human Microbiome Based Drugs and Diagnostics Market Size (M USD) (2019-2030)
Figure 6. Global Human Microbiome Based Drugs and Diagnostics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Microbiome Based Drugs and Diagnostics Market Size by Country (M USD)
Figure 11. Human Microbiome Based Drugs and Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Human Microbiome Based Drugs and Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Microbiome Based Drugs and Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Microbiome Based Drugs and Diagnostics Market Share by Type
Figure 18. Sales Market Share of Human Microbiome Based Drugs and Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Human Microbiome Based Drugs and Diagnostics by Type in 2023
Figure 20. Market Size Share of Human Microbiome Based Drugs and Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Human Microbiome Based Drugs and Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application
Figure 24. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application in 2023
Figure 28. Global Human Microbiome Based Drugs and Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Human Microbiome Based Drugs and Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Human Microbiome Based Drugs and Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Human Microbiome Based Drugs and Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Human Microbiome Based Drugs and Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region in 2023
Figure 44. China Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Human Microbiome Based Drugs and Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Human Microbiome Based Drugs and Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Human Microbiome Based Drugs and Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Human Microbiome Based Drugs and Diagnostics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Microbiome Based Drugs and Diagnostics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Microbiome Based Drugs and Diagnostics Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Microbiome Based Drugs and Diagnostics Sales Forecast by Application (2025-2030)
Figure 66. Global Human Microbiome Based Drugs and Diagnostics Market Share Forecast by Application (2025-2030)